Modeling the number and size of hepatic focal lesions following exposure to 2,3,7,8-TCDD

Toxicology and Applied Pharmacology

Volumn 138, Issue 1, 1996, Pages 20-30

  Portier, C J ^a   Sherman, C D ^a   Kohn, M ^a   Edler, L ^b   Kopp Schneider, A ^b   Maronpot, R M ^a   Lucier, G ^a  

^a NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

^b GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

2,3,7,8 TETRACHLORODIBENZO PARA DIOXIN; DIETHYLNITROSAMINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; FEMALE; LIVER CARCINOGENESIS; LIVER FOCAL NODULAR HYPERPLASIA; MATHEMATICAL MODEL; MODEL; NONHUMAN; RAT;

ANIMALIA;

EID: 0029942977     PISSN: 0041008X     EISSN: None     Source Type: Journal    
DOI: 10.1006/taap.1996.0093     Document Type: Article

References (32)

1. Anderson, E., and the Carcinogen Assessment Group (1983). Quantitative approaches in use to assess cancer risk. Risk Anal. 3, 277-295.
2. Appel, K., Furstenberger, G., Hapke, H., Hecker, E., Hildebrandt, A., Koransky, W., Marks, F., Neumann, H., Ohnesorge, F., and Schulte-Hermann, R. (1990). Chemical carcinogenesis: Definitions and frequently used terms. J. Cancer Res. Clin. Oncol. 116, 232-236.
3. Armitage, P., and Doll, R. (1957). A two-stage theory of carcinogenesis in relation to the age distribution of human cancer. Br. J. Cancer 11, 161-169.
4. Dewanji, A., Venzon, D., and Moolgavkar, S. (1989). A stochastic two-stage model for cancer risk assessment. II. The number and size of premalignant clones. Risk Anal. 9, 179-187.
5. Dragan, Y. P., Xu, X., Goldsworthy, T., Campbell, H., Maronpot, R., and Pitot, H. (1992). Characterization of the promotion of altered hepatic foci by 2,3,7,8-tetrachlorodibenzo-p-dioxin in the female rat. Carcinogenesis 13, 1389-1395.
6. EPA (1985). Health assessment document for polychlorinated dibenzo-p-dioxins, document EPA/600/8-84-014F. Office of Health and Environmental Assessment, Cincinnati.
7. Eriksson, M., Hardell, L., and Adami, H. O. (1990). Exposure to dioxins as a risk factor for soft-tissue sarcoma: A population based case-control study. J. Natl. Cancer Inst. 82, 486-490.
8. Feller, W. (1962). An Introduction to Probability Theory and Its Applications: Volume 2. Wiley, New York.
9. Fingerhut, M. A., Halperin, W. E., Marlow, D. A., Piacitelli, L. A., Honchar, P. A., Sweeney, M. H., Greife, A. L., Dill, P. A., Steenland, K., and Suruda, A. J. (1991). Cancer mortality in workers exposed to 2,3,7,8-tetrachlorodibenzo-p-dioxin. N. Engl. J. Med. 324, 212-218.
10. Goldsworthy, T., Hanigan, M., and Pitot, H. (1986). Models of hepatocarcinogenesis in the rat - Contrasts and comparisons. CRC Crit. Rev. Toxicol. 17, 61-89.
11. Graham, M. J., Lucier, G. W., Linko, P., Maronpot, R. R., and Goldstein, J. (1988). Increases in cytochrome p-450 mediated 17b-estradiol 2-hydroxylase activity in rat liver microsomes after both acute administration and subchronic administration of 2,3,7,8-tetrachlorodibenzo-p-dioxin in a two-stage hepatocarcinogenesis model. Carcinogenesis 9, 1935-1941.
12. Kociba, R. J., Keyes, D. G., Beyer, J., et al. (1978). Results of a two-year chronic toxicity and oncogenicity study of 2,3,7,8-tetrachlorodibenzo-p-dioxin. Toxicol. Appl. Pharmacol. 46, 279-303.
13. Kohn, M., Lucier, G., Clark, G., Sewall, C., Tritscher, A., and Portier, C. (1993). A mechanistic model of the effects of dioxin on gene expression in the rat liver. Toxicol. Appl. Pharmacol. 120, 138-154.
14. Kopp-Schneider, A., and Portier, C. J. (1992). Birth and death/differentiation rates of papillomas in mouse skin. Carcinogenesis 13, 973-978.
15. Kunz, H., Tennekes, H., Port, E., Schwartz, M., Lorke, D., and Schaude, G. (1983). Quantitative aspects of chemical carcinogenesis and tumor promotion in liver. Environ. Health Perspect. 50, 113-122.
16. Lucier, G. W. (1991). Humans are a sensitive species to some of the biochemical effects of structural analogs of dioxin. Environ. Toxicol. Chem. 10, 727-735.
17. Luebeck, E. G., Moolgavkar, S. H., Buchmann, A., and Schwarz, M. (1991). Effects of polychlorinated biphenyls in rat liver: Quantitative analysis of enzyme-altered foci. Toxicol. Appl. Pharmacol. 111, 469-84.
18. Maronpot, R. R., Foley, J. F., Takahashi, K., Goldsworthy, T., Clark, G., Tritscher, A., Portier, C., and Lucier, G. (1993). Dose-response for TCDD promotion of hepatocarcinogenesis in rats initiated with DEN: Histologic, biochemical and cell proliferation endpoints. Environ. Health Perspect. 101, 634-642.
19. Metzler, M. (1984). Metabolism of stilbene estrogen and steroidal estrogens in relation to carcinogenicity. Arch. Toxicol. 22, 104-109.
20. Moolgavkar, S., and Venzon, D. (1979). Two-event models for carcinogenesis: Incidence curves for childhood and adult tumors. Math. Biosci. 47, 55-77.
21. Moolgavkar, S. H., Luebeck, E. G., de Gunst, M., Port, R. E., and Schwarz, M. (1990). Quantitative analysis of enzyme-altered foci in rat hepatocarcinogenesis experiments. I. Single agent regimen. Carcinogenesis 11, 1271-1278.
22. Moolgavkar, S. and Luebeck, E. (1992). Interpretation of labeling indices in the presence of cell death. Carcinogenesis 13, 1007-1010.
23. National Toxicology Program (NTP) (1982). Carcinogenicity bioassay of 2,3,7,8-tetrachlorodibenzo-p-dioxin in Osborne-Mendel rats and B6C3F1 mice (gavage study), NTP Technical Report Series number 209. Research Triangle Park, NC.
24. Neyman, J., and Scott, E. (1967). Statistical aspects of the problem of carcinogenesis. In Fifth Berkeley Symposium on Mathematical Statistics and Probability, pp. 745-776. Univ. of California Press, Berkeley, CA.
25. Pitot, H., Goldsworthy, T., Moran, S., Kenan, W., Glavert, H., Maronpot, R., and Campbell, H. (1987). A method to quantitate the relative initiating and promoting potencies of hepatocarcinogenic agents in their dose-response relationships to altered hepatic foci. Carcinogenesis 8, 1491-1499.
26. Portier, C. (1987). Statistical properties of a two-stage model of carcinogenesis. Environ. Health Perspect. 76, 125-132.
27. Portier, C., Hoel, D., and Van Ryzin, J. (1984). Statistical analysis of the carcinogenesis bioassay data relating to the risks from exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin. In Public Health Risks of the Dioxins (W. Lowrance, Ed.), pp. 99-120. Kaufmann, Los Altos, CA.
28. Portier, C. J., Tritscher, A., Kohn, M., Sewall, C., Clark, G., Edler, L., Hoel, D., and Lucier, G. (1993). Ligand-receptor binding for 2,3,7,8-TCDD: Implications for risk assessment. Fundam. Appl. Toxicol. 20,48-56.
29. Press, W., Flannery, B., Teukolsky, S., and Vetterling, W. (1988). Numerical Recipes. Cambridge Univ. Press, New York.
30. Sewall, C., Lucier, G., Tritscher, A., and Clark, G. (1993). TCDD-mediated changes in hepatic epidermal growth factor receptor may be a critical event in the hepatocarcinogenic action of TCDD. Carcinogenesis 14, 1885-1893.
31. Tritscher, A., Goldstein, J., Portier, C., McCoy, Z., Clark, G., and Lucier, G. (1992). Dose-response relationships for chronic exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin in a rat tumor promotion model: Quantification and immunolocalization of CYP1A1 and CYP1A2 in the liver. Cancer Res. 52, 3436-3442.
32. Yang, J. H., Thraves, P., Dritschilo, A., and Rhim, J. S. (1992). Neoplastic transformation of immortalized human keratinocytes by 2,3,7,8-tetrachlorodibenzo-p-dioxin. Cancer Res. 52, 3478-3482.